Skip to main content
Top
Published in: European Journal of Nutrition 4/2012

01-06-2012 | Original Contribution

Effect of consumption of tomato juice enriched with n-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women

Authors: F. J. García-Alonso, V. Jorge-Vidal, G. Ros, M. J. Periago

Published in: European Journal of Nutrition | Issue 4/2012

Login to get access

Abstract

Purpose

We compared the effects of consumption of n-3 polyunsaturated fatty acids (PUFA)-enriched tomato juice versus plain tomato juice on the serum lipid profile and levels of biomarkers related to antioxidant status and cardiovascular disease (CVD) risk in women.

Methods

Eighteen healthy women participated in a 2-week intervention trial involving the daily intake of 500 mL of n-3 PUFA-enriched juice (n = 11) or plain tomato juice (n = 7). Each serving of enriched juice provided 250 mg of eicosapentaenoic acid (EPA) plus docosahexanoic acid (DHA). Both juices provided natural antioxidant compounds such as phenolics (181 mg) and lycopene (26.5 mg).

Results

Intervention with the enriched juice had no effect on the lipid profile, and serum levels of triglycerides and cholesterol (total, LDL, and HDL) remained unchanged. The serum antioxidant status improved following juice intake, as revealed by an increase in total antioxidant capacity and a slight decrease in lipid peroxidation. The serum levels of homocysteine, a cardiovascular risk factor, decreased following n-3 PUFA-enriched juice consumption. A decrease in vascular adhesion molecule 1 (VCAM-1) levels was also noted after intake of either plain or enriched tomato juice, whereas intercellular adhesion molecule 1 (ICAM-1) levels only decreased following intake of the enriched juice.

Conclusions

Overall, stronger positive amelioration of CVD risk factors was observed following the intake of n-3 PUFA-enriched juice than after plain tomato juice consumption, which suggested a possible synergistic action between n-3 PUFAs and tomato antioxidants.
Literature
1.
go back to reference Das UN (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and, and cardioprotective molecules. Lipids Health Dis 7:37–55CrossRef Das UN (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and, and cardioprotective molecules. Lipids Health Dis 7:37–55CrossRef
2.
go back to reference Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M (2006) ACE enzyme inhibitors, anti-arrhytmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 27(13):1610–1619CrossRef Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M (2006) ACE enzyme inhibitors, anti-arrhytmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 27(13):1610–1619CrossRef
3.
go back to reference Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Heart disease and stroke statistics-2010 Update. A report from the American Heart Association. Circulation 121:e46–e215CrossRef Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Heart disease and stroke statistics-2010 Update. A report from the American Heart Association. Circulation 121:e46–e215CrossRef
4.
go back to reference Maas R, Böger RH (2003) Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atheroscler Suppl 4:5–17CrossRef Maas R, Böger RH (2003) Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atheroscler Suppl 4:5–17CrossRef
5.
go back to reference Bhatnagar D, Durrington PN (2003) Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 57:305–314 Bhatnagar D, Durrington PN (2003) Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 57:305–314
6.
go back to reference Nishida C, Uauy R, Kumanyika S, Shetty P (2004) The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 7:245–250 Nishida C, Uauy R, Kumanyika S, Shetty P (2004) The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 7:245–250
7.
go back to reference De Caterina R, Massaro M (2005) Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol 206:103–116CrossRef De Caterina R, Massaro M (2005) Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol 206:103–116CrossRef
8.
go back to reference Calder PC, Yaqoob P (2009) Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 35:266–272CrossRef Calder PC, Yaqoob P (2009) Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 35:266–272CrossRef
9.
go back to reference Lavie CJ, Milani RV, Mehra MR, Ventura HO (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol (JACC) 54:585–594CrossRef Lavie CJ, Milani RV, Mehra MR, Ventura HO (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol (JACC) 54:585–594CrossRef
10.
go back to reference Patel JV, Tracey I, Hughes EA, Lip GYH (2000) Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy. Vasc Health Risk Manag 5:801–810 Patel JV, Tracey I, Hughes EA, Lip GYH (2000) Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy. Vasc Health Risk Manag 5:801–810
11.
go back to reference De Roos B, Mavromatis Y, Brouwer IA (2009) Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 158:413–428CrossRef De Roos B, Mavromatis Y, Brouwer IA (2009) Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 158:413–428CrossRef
12.
go back to reference Vrablik M, Prusikova M, Snejdrlova M, Zlatohlavek L (2009) Omega-3 fatty acids and cardiovascular disease risk. Do we understand the relationship? Physiol Res 58((Suppl 1)):S19–S26 Vrablik M, Prusikova M, Snejdrlova M, Zlatohlavek L (2009) Omega-3 fatty acids and cardiovascular disease risk. Do we understand the relationship? Physiol Res 58((Suppl 1)):S19–S26
13.
go back to reference He K (2009) Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease-Eat fish or take fish oil supplement? Prog Cardiovasc Dis 52:95–114CrossRef He K (2009) Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease-Eat fish or take fish oil supplement? Prog Cardiovasc Dis 52:95–114CrossRef
14.
go back to reference World Health Organization (1985) Energy and protein requirements. Technical Report Series, No. 724. Report of a Joint FAO/WHO/UNU Expert Consultation. World Health Organization. Geneva World Health Organization (1985) Energy and protein requirements. Technical Report Series, No. 724. Report of a Joint FAO/WHO/UNU Expert Consultation. World Health Organization. Geneva
16.
go back to reference Kris-Etherton PM, Grieger JA, Etherton TD (2009) Dietary reference intakes for DHA and EPA. Prostag Leukotr Ess 81:99–104CrossRef Kris-Etherton PM, Grieger JA, Etherton TD (2009) Dietary reference intakes for DHA and EPA. Prostag Leukotr Ess 81:99–104CrossRef
17.
go back to reference Wallace JM, McCabe AJ, Robson PJ, Keogh MK, Murray CA, Kelly PM, Marquez-Ruiz G, McGlynn H, Gilmore WS, Strain JJ (2000) Bioavailability of n-3 polyunsaturated fatty acids (PUFA) in foods enriched with microencapsulated fish oil. Ann Nutr Metab 44:157–162CrossRef Wallace JM, McCabe AJ, Robson PJ, Keogh MK, Murray CA, Kelly PM, Marquez-Ruiz G, McGlynn H, Gilmore WS, Strain JJ (2000) Bioavailability of n-3 polyunsaturated fatty acids (PUFA) in foods enriched with microencapsulated fish oil. Ann Nutr Metab 44:157–162CrossRef
18.
go back to reference Whelan J, Rust C (2006) Innovative dietary sources of n-3 fatty acids. Ann Rev Nutr 26:75–103CrossRef Whelan J, Rust C (2006) Innovative dietary sources of n-3 fatty acids. Ann Rev Nutr 26:75–103CrossRef
19.
go back to reference Kolanowsky W, Swiderski F, Berger S (1999) Possibilities of fish oil application for food products enrichment with omega-3 PUFA. Int J Food Sci Nutr 50:39–49CrossRef Kolanowsky W, Swiderski F, Berger S (1999) Possibilities of fish oil application for food products enrichment with omega-3 PUFA. Int J Food Sci Nutr 50:39–49CrossRef
20.
go back to reference Metcalf RG, James MJ, Mantzioris E, Cleland LG (2003) A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats. Eur J Clin Nutr 57:1605–1612CrossRef Metcalf RG, James MJ, Mantzioris E, Cleland LG (2003) A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats. Eur J Clin Nutr 57:1605–1612CrossRef
21.
go back to reference Martin L, Zarn D, Hansen AM, Wismer W, Mazurak V (2008) Food products as vehicles for n-3 fatty acid supplementation. Can J Diet Pract Res 69:203–207CrossRef Martin L, Zarn D, Hansen AM, Wismer W, Mazurak V (2008) Food products as vehicles for n-3 fatty acid supplementation. Can J Diet Pract Res 69:203–207CrossRef
22.
go back to reference Periago MJ, García-Alonso FJ, Jacob K, Olivares AB, Bernal MJ, Iniesta MD, Martínez C, Ros G (2008) Bioactive compounds, folates and antioxidant properties of tomatoes (Lycopersicum esculentum) during vine ripening. Int J Food Sci Nutr 12:1–15CrossRef Periago MJ, García-Alonso FJ, Jacob K, Olivares AB, Bernal MJ, Iniesta MD, Martínez C, Ros G (2008) Bioactive compounds, folates and antioxidant properties of tomatoes (Lycopersicum esculentum) during vine ripening. Int J Food Sci Nutr 12:1–15CrossRef
23.
go back to reference Garcia-Alonso FJ, Bravo S, Casas J, Pérez-Conesa D, Jacob K, Periago MJ (2009) Changes in antioxidant compounds during the shelf life of commercial tomato juices in different packaging materials. J Agric Food Chem 57:6815–6822CrossRef Garcia-Alonso FJ, Bravo S, Casas J, Pérez-Conesa D, Jacob K, Periago MJ (2009) Changes in antioxidant compounds during the shelf life of commercial tomato juices in different packaging materials. J Agric Food Chem 57:6815–6822CrossRef
24.
go back to reference Rao AV (2002) Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med 227:908–913 Rao AV (2002) Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med 227:908–913
25.
go back to reference Wilcox JK, Catignani GL, Lazarus S (2003) Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 43(1):1–18CrossRef Wilcox JK, Catignani GL, Lazarus S (2003) Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 43(1):1–18CrossRef
26.
go back to reference Iniesta MD, Pérez-Conesa D, García-Alonso FJ, Ros G, Periago MJ (2009) Folate content in tomato (Lycopersicum esculentum). Influence of cultivar, ripeness, year of harvest and pasteurization and storage temperatures. J Agric Food Chem 57:4739–4745CrossRef Iniesta MD, Pérez-Conesa D, García-Alonso FJ, Ros G, Periago MJ (2009) Folate content in tomato (Lycopersicum esculentum). Influence of cultivar, ripeness, year of harvest and pasteurization and storage temperatures. J Agric Food Chem 57:4739–4745CrossRef
27.
go back to reference Aguilar B, Rojas JC, Collados MT (2004) Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolys 18:75–87CrossRef Aguilar B, Rojas JC, Collados MT (2004) Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolys 18:75–87CrossRef
28.
go back to reference Jacob K, Periago MJ, Böhm V, Berruezo GR (2008) Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. Br J Nutr 99:137–146CrossRef Jacob K, Periago MJ, Böhm V, Berruezo GR (2008) Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. Br J Nutr 99:137–146CrossRef
29.
go back to reference Castelli WP (1988) Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study. Can J Cardiol 4(Suppl A):5A–10A Castelli WP (1988) Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study. Can J Cardiol 4(Suppl A):5A–10A
30.
go back to reference Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Method Enzymol 52:302–310CrossRef Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Method Enzymol 52:302–310CrossRef
31.
go back to reference Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolf SP (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenilphosphine. Anal Biochem 220:403–409CrossRef Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolf SP (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenilphosphine. Anal Biochem 220:403–409CrossRef
32.
go back to reference Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA (1996) Antioxidant activities of carotenes and xanthophylls. Fed Eur Biochem Soc Lett 384:240–242CrossRef Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA (1996) Antioxidant activities of carotenes and xanthophylls. Fed Eur Biochem Soc Lett 384:240–242CrossRef
33.
go back to reference Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76CrossRef Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76CrossRef
34.
go back to reference Esteve MJ, Farré R, Frígola A, López JC, Romera JM, Ramírez M, Gil A (1995) Comparison of voltammetric and high performance liquid chromatographic methods for ascorbic acid determination in infant formulas. Food Chem 52:99–102CrossRef Esteve MJ, Farré R, Frígola A, López JC, Romera JM, Ramírez M, Gil A (1995) Comparison of voltammetric and high performance liquid chromatographic methods for ascorbic acid determination in infant formulas. Food Chem 52:99–102CrossRef
35.
go back to reference MacCrehan WA (1990) Determination of retinol, α-tocopherol and β-carotene in serum by liquid chromatography. Method Enzymol 189:172–181CrossRef MacCrehan WA (1990) Determination of retinol, α-tocopherol and β-carotene in serum by liquid chromatography. Method Enzymol 189:172–181CrossRef
36.
go back to reference Baró L, Fonollá J, Peña JL, Martínez-Férez A, Lucena A, Jiménez J, Boza JJ, López-Huertas E (2003) n-3 fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr 22:175–182CrossRef Baró L, Fonollá J, Peña JL, Martínez-Férez A, Lucena A, Jiménez J, Boza JJ, López-Huertas E (2003) n-3 fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr 22:175–182CrossRef
37.
go back to reference Carrero JJ, Fonollá J, Mart JL, Jimenez J, Boza JJ, Lopez-Huertas E (2007) Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma-C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr 137:384–390 Carrero JJ, Fonollá J, Mart JL, Jimenez J, Boza JJ, Lopez-Huertas E (2007) Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma-C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr 137:384–390
38.
go back to reference Benito P, Caballero J, Moreno J, Gutiérrez-Alcántara C, Muñoz C, Rojo G, Garcia S, Soriguer FC (2006) Effects of milk enriched with ω-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 25:581–587CrossRef Benito P, Caballero J, Moreno J, Gutiérrez-Alcántara C, Muñoz C, Rojo G, Garcia S, Soriguer FC (2006) Effects of milk enriched with ω-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 25:581–587CrossRef
39.
go back to reference Raghu B, Venkatesan P (2008) Effect of n-3 fatty acid supplementation on blood glucose, lipid profile and cytokines in humans: a pilot study. Ind J Clin Biochem 23:85–88CrossRef Raghu B, Venkatesan P (2008) Effect of n-3 fatty acid supplementation on blood glucose, lipid profile and cytokines in humans: a pilot study. Ind J Clin Biochem 23:85–88CrossRef
40.
go back to reference Fuhrman B, Elis A, Aviram M (1997) Hypocholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Bioph Res Co 233(3):658–662CrossRef Fuhrman B, Elis A, Aviram M (1997) Hypocholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Bioph Res Co 233(3):658–662CrossRef
41.
go back to reference Schmidt EB, Lervang HH, Varming K, Madsen P, Dyeberg J (1992) Lon-term supplementation with n-3 fatty acids, I: effect on blood lipids, haemostasis and blood pressure. Scand J Clin Lab Inv 52:221–228CrossRef Schmidt EB, Lervang HH, Varming K, Madsen P, Dyeberg J (1992) Lon-term supplementation with n-3 fatty acids, I: effect on blood lipids, haemostasis and blood pressure. Scand J Clin Lab Inv 52:221–228CrossRef
42.
go back to reference Ridker P (2003) Expert opinions: clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363–369CrossRef Ridker P (2003) Expert opinions: clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363–369CrossRef
43.
go back to reference López-García E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB (2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134:1086–1811 López-García E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB (2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134:1086–1811
44.
go back to reference Shen YC, Chen SL, Wang CK (2007) Contribution of tomato phenolics to antioxidation and down-regulation of blood lipids. J Agric Food Chem 55:6475–6481CrossRef Shen YC, Chen SL, Wang CK (2007) Contribution of tomato phenolics to antioxidation and down-regulation of blood lipids. J Agric Food Chem 55:6475–6481CrossRef
45.
go back to reference Thorlaksdottir AY, Skuladottir GV, Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM, Eyfjord JE, Jonsson JJ, Hardardottir I (2006) Positive association between plasma antioxidant capacity and n-3 PUFA in red blood cells from women. Lipids 41:119–126CrossRef Thorlaksdottir AY, Skuladottir GV, Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM, Eyfjord JE, Jonsson JJ, Hardardottir I (2006) Positive association between plasma antioxidant capacity and n-3 PUFA in red blood cells from women. Lipids 41:119–126CrossRef
46.
go back to reference Erdogan H, Fadillioglu E, Ozgocmen S, Sogut S, Ozyurt B, Akyol O, Ardicoglu O (2004) Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats. Prostag Leukotr Ess 71:149–152CrossRef Erdogan H, Fadillioglu E, Ozgocmen S, Sogut S, Ozyurt B, Akyol O, Ardicoglu O (2004) Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats. Prostag Leukotr Ess 71:149–152CrossRef
47.
go back to reference Clarke R, Armitage J (2000) Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26:341–348CrossRef Clarke R, Armitage J (2000) Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26:341–348CrossRef
48.
go back to reference Stanger O, Semmelrock HJ, Wonisch W, Bös U, Pabst E, Wascher TC (2002) Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 303:158–162CrossRef Stanger O, Semmelrock HJ, Wonisch W, Bös U, Pabst E, Wascher TC (2002) Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 303:158–162CrossRef
49.
go back to reference Ueland PM, Refsum H, Beresford SA, Wollset SE (2000) The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 72:324–332 Ueland PM, Refsum H, Beresford SA, Wollset SE (2000) The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 72:324–332
50.
go back to reference Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB (2002) Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case control studies. Int J Epidemiol 31:59–70CrossRef Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB (2002) Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case control studies. Int J Epidemiol 31:59–70CrossRef
51.
go back to reference Huang T, Wahlqvist ML, Li D (2010) Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and nRNA expression involved in methionine metabolism. Nutrition 26:112–119CrossRef Huang T, Wahlqvist ML, Li D (2010) Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and nRNA expression involved in methionine metabolism. Nutrition 26:112–119CrossRef
52.
go back to reference Grundt H, Nilsen DWT, Mansoor MA, Hetland O, Nordoy A (2003) Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomized double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 33:88–95CrossRef Grundt H, Nilsen DWT, Mansoor MA, Hetland O, Nordoy A (2003) Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomized double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 33:88–95CrossRef
53.
go back to reference Chi Z, Melendez AJ (2007) Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis. Cell Adh Migr 1:171–175CrossRef Chi Z, Melendez AJ (2007) Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis. Cell Adh Migr 1:171–175CrossRef
54.
go back to reference Miles EA, Thies F, Wallace FA, Powell JR, Hurst TL, Newsholme EA, Calder PC (2001) Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci (Lond) 100:91–100CrossRef Miles EA, Thies F, Wallace FA, Powell JR, Hurst TL, Newsholme EA, Calder PC (2001) Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci (Lond) 100:91–100CrossRef
55.
go back to reference Liu X, Qu D, He F, Lu Q, Wang J, Cai D (2007) Effect of lycopene on the vascular endothelial function and expression of inflammatory agents in hyperhomocysteinemic rats. Asia Pac J Clin Nutr 16:244–248 Liu X, Qu D, He F, Lu Q, Wang J, Cai D (2007) Effect of lycopene on the vascular endothelial function and expression of inflammatory agents in hyperhomocysteinemic rats. Asia Pac J Clin Nutr 16:244–248
56.
go back to reference Blum A, Moni M, Khazim K, Peleg A, Blum N (2007) Tomato-rich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med 30(2):E70–E74 Blum A, Moni M, Khazim K, Peleg A, Blum N (2007) Tomato-rich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med 30(2):E70–E74
57.
go back to reference Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012–17017CrossRef Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012–17017CrossRef
58.
go back to reference Mestas J, Ley K (2008) Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 18:228–232CrossRef Mestas J, Ley K (2008) Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 18:228–232CrossRef
59.
go back to reference Rizzo M, Kotur-Stevuljevic J, Berneis K, Spinas G, Rini BG, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Vekic J (2009) Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 153:217–223CrossRef Rizzo M, Kotur-Stevuljevic J, Berneis K, Spinas G, Rini BG, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Vekic J (2009) Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 153:217–223CrossRef
Metadata
Title
Effect of consumption of tomato juice enriched with n-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women
Authors
F. J. García-Alonso
V. Jorge-Vidal
G. Ros
M. J. Periago
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
European Journal of Nutrition / Issue 4/2012
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-011-0225-0

Other articles of this Issue 4/2012

European Journal of Nutrition 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.